Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
BEAM:NASDAQ
Beam Therapeutics Inc
$28.64
+3.51%
(+0.97) 1D
$28.50
-0.49% (-0.14)
After hours
Closed: May 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BEAM...
Open
$27.70
High
$29.14
Low
$27.63
Mkt. cap
2.95B
Avg. vol.
2.17M
Volume
1.33M
52-wk high
$36.44
52-wk low
$15.35
EPS
-$0.64
Beta
2.26
Shares outstanding
102.88M
No. of employees
522
News stories
From sources across the web
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc
CEOJohn Evans
Employees522
Founded2017
Headquarters-
SectorBiotechnology
Websitebeamtx.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.91 / -$1.01
+9.63%beat
Revenue / Est. (USD)
31.74M / 12.48M
+154.36%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.47M
9.70M
114.11M
31.74M
Cost of goods sold
101.76M
109.77M
99.28M
11.06M
Cost of revenue
101.76M
109.77M
99.28M
11.06M
Research and development expenses
-
-
-
93.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.86M
26.74M
32.28M
34.43M
Operating expense
26.86M
26.74M
32.28M
127.90M
Total operating expenses
128.62M
136.51M
131.55M
138.95M
Operating income
-120.15M
-126.81M
-17.44M
-107.22M
Other non operating income
1.15M
8.55M
50.00K
2.50M
EBT including unusual items
-102.29M
-112.73M
244.30M
-94.32M
EBT excluding unusual items
-106.68M
-118.26M
248.39M
-94.85M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-102.29M
-112.73M
244.30M
-94.32M
Net profit margin
-1,208.26%
-1,162.38%
214.09%
-297.18%
Earnings per share
-1.00
-1.10
2.33
-0.91
Interest and investment income
12.33M
-
10.64M
9.87M
Interest expense
-
-
-
-
Net interest expenses
12.33M
-
10.64M
9.87M
Depreciation and amortization charges
-
-
-
-
EBITDA
-114.61M
-121.25M
-11.78M
-101.61M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer